US FTC sues to block Cencora's $3.5 billion sale of veterinary unit to Covetrus

Impact · against what's priced in

The FTC's move to block the MWI Animal Health sale is a negative catalyst for both companies. For Cencora, it removes a multi-billion dollar liquidity event not currently factored into its conservative valuation; for Covetrus, it halts a major market share expansion.

COR−0.30: Not in the price yet
In context: The market is currently focused on pharmaceutical distribution headwinds and lowered revenue guidance; the loss of a $3.5 billion liquidity event from the MWI sale is a new negative development.
What COR's price assumes · Sep 13

US FTC sues to block Cencora's $3.5 billion sale of veterinary unit to Covetrus

m and a▲4%
lawsuit
regulation
healthcare
COR
CVTR
antitrust
veterinary

Top 1 mover · tap to explore

US FTC sues to block Cencora's $3.5 billion sale of veterinary unit to Covetrus

What matters in this story

How each ticker is affected

Curaleaf Unlikely To Acquire Aurora Cannabis, But Long-Term Potential Remains

US FTC sues to block Cencora's $3.5 billion sale of veterinary unit to Covetrus

What matters in this story

How each ticker is affected

Curaleaf Unlikely To Acquire Aurora Cannabis, But Long-Term Potential Remains

Connected tickers

Track these names every morning.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - SMR

Why the data center slowdown concern is overblown. Two stocks to buy amid the fear

Utah Medical Products: A $25 Million Buyback Isn't Enough

NVDA CLASS ACTION UPDATE: Rosen Law Firm Expands Class Period to Include More NVIDIA Corporation Investors in Securities Class Action First Filed by the Firm - NVDA

US FTC sues to block Cencora's $3.5 billion sale of veterinary unit to Covetrus

What matters in this story

How each ticker is affected

Next reads from the same story arc

Curaleaf Unlikely To Acquire Aurora Cannabis, But Long-Term Potential Remains

US FTC sues to block Cencora's $3.5 billion sale of veterinary unit to Covetrus

What matters in this story

How each ticker is affected

Next reads from the same story arc

Curaleaf Unlikely To Acquire Aurora Cannabis, But Long-Term Potential Remains

Connected tickers

Track these names every morning.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - SMR

Why the data center slowdown concern is overblown. Two stocks to buy amid the fear

Utah Medical Products: A $25 Million Buyback Isn't Enough

NVDA CLASS ACTION UPDATE: Rosen Law Firm Expands Class Period to Include More NVIDIA Corporation Investors in Securities Class Action First Filed by the Firm - NVDA